Beam Therapeutics files lawsuit accusing former scientist of stealing IP to launch Chinese biotech venture
read at STAT ↗CRLNegative
Beam Therapeutics has initiated legal action alleging that a former employee misappropriated proprietary gene-editing technology.
The company claims the scientist used the stolen information to co-found a new Chinese biotech firm, which subsequently secured venture-capital financing.
The lawsuit highlights ongoing concerns about intellectual-property protection in the rapidly evolving CRISPR and gene-editing sector.
source
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Pharmalittle: We’re reading about Beam suing over IP theft, a Trump rule on importing meds, and more”
read at STAT ↗672 words · retrieved 2h ago
comments(0)
5-min edit window · permanent after that